Skip to content
Recall Observatory FDA recall evidence

Drug product

Olopatadine HCl Ophthalmic Solution, USP 0.1%, 5 mL (0.17 FL OZ) per bottle, Antihistamine and Redness Reliever, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. Marketed by: GSMS, Incorporated, Camarillo, CA 93012. NDC: 51407-499-05

D-0150-2023

October 13, 2022

Class II

Product summary

Firm
Akorn, Inc.
Event
Event 90948
Status
Ongoing
Classification
Class II
Quantity
163,996 bottles
Official record key
drug-enforcement:D-0150-2023

Official wording

Reason: CGMP Deviations:

Code information: Lot: 1L16A, 1L17A, EXP 10/31/2023; 1M29A, EXP 11/30/2023; 2A05A, EXP 12/31/2023;

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations